What if a rare and deadly form of lung cancer, long considered a near-hopeless battle, suddenly had a new weapon in its fight? Picture a patient, grappling with the weight of a diagnosis of HER2-mutant non-small cell lung cancer (NSCLC), now finding a glimmer of possibility with an oral therapy
Imagine a crime scene where a single drop of blood holds the key to identifying a suspect, not just by DNA but by estimating their age with remarkable precision, a technique that has become invaluable in modern investigations. Forensic age estimation tools, relying on DNA methylation patterns, have
Welcome to an insightful conversation with Dr. Ivan Kairatov, a distinguished neurosurgeon renowned for his expertise in rare skull base tumors and innovative surgical techniques. With a focus on sellar chondrosarcomas—a particularly uncommon and challenging condition—Dr. Kairatov has been at the
Mantle cell lymphoma (MCL), a rare yet aggressive form of blood cancer, affects approximately one in every 100,000 individuals annually, falling within the broader category of lymphoma, which ranks as the sixth most common cancer worldwide. Despite its relative rarity, the disease poses a
Drug discovery has long been a daunting endeavor, with the staggering statistic that developing a single new drug can cost upwards of $1 billion and take over a decade to reach the market. Imagine a world where this timeline is slashed, costs are dramatically reduced, and even smaller research
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, particularly in cutting-edge technologies and innovations in the industry. Today, we’re diving into a groundbreaking advancement in cancer treatment—a new formulation of
